Paid Research Studies in New York

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in New York

Top of Directory » All Locations » United States » New York




  • Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

    Conditions:   Squamous Cell Cancer;   Head and Neck Cancer
    Intervention:   Drug: Temsirolimus + Weekly Paclitaxel + Carboplatin
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   NATL COMP CA NETWORK;   Wyeth
    Recruiting - verified November 2009

  • Effects of Intensified Sodium Management in Hemodialysis Patients

    Condition:   Hemodialysis
    Intervention:   Other: intensive sodium management
    Sponsor:   Renal Research Institute
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis

    Condition:   Ulcerative Proctitis
    Interventions:   Procedure: Proctosigmoidoscopy or colonoscopy with biopsy;   Procedure: Proctosigmoidoscopy;   Procedure: Blood collection;   Procedure: Electrocardiogram (ECG);   Drug: MAX-002;   Drug: Canasa®;   Drug: Placebo
    Sponsor:   Axcan Pharma
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation

    Condition:   Persistent Atrial Fibrillation
    Interventions:   Drug: Ibutilide;   Drug: Placebo
    Sponsors:   Mount Sinai School of Medicine;   St. Jude Medical
    Recruiting - verified November 2009

  • A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

    Conditions:   Carcinoma;   Ovarian Cancer;   Ovarian Diseases;   Ovarian Neoplasms
    Interventions:   Biological: AGS-8M4;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: gemcitabine;   Drug: carboplatin
    Sponsors:   Astellas Pharma Inc;   Agensys, Inc.
    Recruiting - verified November 2009

  • Diabetes Support Project: Couples Intervention

    Condition:   Type 2 Diabetes
    Interventions:   Behavioral: Telephone support and behavior change;   Other: Diabetes self-management education
    Sponsor:   State University of New York - Upstate Medical University
    Not yet recruiting - verified November 2009

  • Magnetic Resonance Imaging (MRI) Interpretations for Lumbar Spinal Stenosis (LSS)

    Condition:   Lumbar Spinal Stenosis
    Intervention:   Procedure: MRI
    Sponsor:   State University of New York - Upstate Medical University
    Recruiting - verified November 2009

  • A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

    Condition:   HIV Infections
    Interventions:   Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
    Sponsors:   New York University;   St. Vincent's Medical Center
    Not yet recruiting - verified November 2009

  • Study of Lung Chemotherapy in the Treatment of Advanced Lung Cancer and Metastatic Sarcoma

    Conditions:   Lung Cancer;   Sarcoma
    Intervention:   Drug: Cisplatin
    Sponsor:   Roswell Park Cancer Institute
    Recruiting - verified November 2009

  • Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis

    Condition:   Primary Myelofibrosis
    Intervention:   Drug: Dose Escalating Arsenic Trioxide plus ascorbic Acid
    Sponsors:   Roswell Park Cancer Institute;   Cephalon
    Not yet recruiting - verified November 2009

  • Percutaneous Renal Tumor Cryoablation Followed by Biopsy

    Condition:   Renal Cancer
    Intervention:   Procedure: percutaneous cryoablation
    Sponsor:   Memorial Sloan-Kettering Cancer Center
    Recruiting - verified November 2009

  • Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

    Condition:   Adult ADHD
    Interventions:   Drug: AZD1446;   Drug: AZD1446;   Drug: AZD1446;   Drug: Placebo
    Sponsor:   AstraZeneca
    Recruiting - verified November 2009

  • External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

    Condition:   Brain Cancer
    Intervention:   Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   Children's Healthcare of Atlanta;   Dana-Farber Cancer Institute;   M.D. Anderson Cancer Center;   Phoenix Children's Hospital;   Sidney Kimmel Comprehensive Cancer Center;   Alberta Children's Hospital;   University of Colorado at Denver and Health Sciences Center;   University of Florida;   Vanderbilt University
    Recruiting - verified November 2009

  • Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers

    Condition:   Healthy Volunteers
    Intervention:   Drug: Hiltonol (poly ICLC)
    Sponsor:   Rockefeller University
    Recruiting - verified November 2009

  • Promoting Development in Toddlers With Communication Delays

    Conditions:   Parent Child Play;   Maternal Synchrony
    Intervention:   Behavioral: Active Control vs Experimental Treatment
    Sponsor:   Autism Speaks
    Recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

    Conditions:   Chronic Lymphocytic Leukemia;   Leukemia
    Intervention:   Drug: lenalidomide
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   Celgene Corporation
    Recruiting - verified November 2009

  • Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

    Condition:   Leukemia
    Intervention:   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant

    Conditions:   Hypophosphatemia;   Renal Transplant
    Interventions:   Drug: Cinacalcet;   Drug: Placebo
    Sponsor:   Montefiore Medical Center
    Recruiting - verified November 2009

  • Management of Insomnia in Breast Cancer Patients

    Conditions:   Insomnia;   Fatigue
    Interventions:   Drug: Armodafinil;   Behavioral: Brief Behavioral Intervention for Insomnia;   Drug: Placebo
    Sponsors:   University of Rochester;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2009

  • Metoclopramide Versus Ketorolac for Tension-type Headache

    Condition:   Headache
    Interventions:   Drug: Metoclopramide;   Drug: Ketorolac
    Sponsor:   Montefiore Medical Center
    Recruiting - verified November 2009

  • Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia

    Condition:   Leukemia
    Interventions:   Genetic: fluorescence in situ hybridization;   Genetic: mutation analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: flow cytometry;   Other: laboratory biomarker analysis
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Adjuvant Valproate for High Grade Sarcomas

    Condition:   High Grade Sarcoma
    Intervention:   Drug: Valproic Acid
    Sponsor:   Columbia University
    Recruiting - verified November 2009

  • Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) - A Pilot Study

    Condition:   Hematopoietic Stem Cell Transplantation
    Intervention:   Dietary Supplement: Lactobacillus plantarum strains 299 and 299v
    Sponsors:   Columbia University;   All Children's Hospital
    Not yet recruiting - verified November 2009

  • The Use of Music for Pain and Anxiety Control During Abortion

    Conditions:   Pain;   Anxiety
    Intervention:   Other: iPod Nano digital music player
    Sponsors:   Columbia University;   Family Planning Fellowship
    Recruiting - verified November 2009

  • Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: Southern blotting;   Genetic: cytogenetic analysis;   Genetic: polymerase chain reaction
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery

    Conditions:   Inflammation;   Pain
    Interventions:   Drug: Vehicle of Loteprednol Etabonate;   Drug: Loteprednol Etabonate
    Sponsor:   Bausch & Lomb, Inc.
    Not yet recruiting - verified November 2009

  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients

    Conditions:   Non-dipper;   Nocturnal Hypertension
    Interventions:   Drug: Time change;   Drug: Enalapril, Isradapine, Propranolol
    Sponsors:   North Shore Long Island Jewish Health System;   Children's Hospital of Philadelphia
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

    Condition:   Ovarian Cancer
    Intervention:   Drug: erlotinib
    Sponsors:   New York University School of Medicine;   OSI Pharmaceuticals
    Recruiting - verified October 2009

  • Treatment for Depressed Primary Care Patients

    Condition:   Depression
    Interventions:   Behavioral: Depression Care Management (DCM);   Behavioral: Enhanced Care
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia

    Conditions:   Cognitive Dysfunction;   Schizophrenia
    Interventions:   Drug: TC-5619;   Drug: Placebo
    Sponsor:   Targacept Inc.
    Not yet recruiting - verified October 2009

  • Allo-antibodies in Pediatric Heart Transplantation

    Condition:   Heart Transplantation
    Intervention:  
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Heart, Lung, and Blood Institute (NHLBI)
    Not yet recruiting - verified October 2009

  • Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

    Conditions:   Bird Flu;   Influenza
    Interventions:   Other: Placebo;   Biological: Ad4-H5-Vtn
    Sponsor:   PaxVax, Inc.
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • A Phase II Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

    Condition:   Adenocarcinoma of Gall Bladder or Biliary Ducts
    Intervention:   Drug: Gemcitabine, Capecitabine and Bevacizumab
    Sponsor:   Roswell Park Cancer Institute
    Not yet recruiting - verified November 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study to Determine if Monitoring of Labor Shortens the Time to Delivery

    Condition:   Pregnancy
    Intervention:   Device: BirthTrack
    Sponsor:   Barnev, Inc.
    Not yet recruiting - verified October 2009

  • Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis

    Condition:   Ulcerative Colitis
    Interventions:   Drug: Asacol (mesalamine), High Dose;   Drug: Asacol (mesalamine), Low Dose
    Sponsor:   Procter and Gamble
    Recruiting - verified October 2009

  • Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma

    Condition:   Diffuse Large B Cell Lymphoma
    Interventions:   Biological: rituximab;   Drug: cyclophosphamide;   Drug: vincristine;   Drug: doxorubicin;   Drug: prednisone;   Drug: azacytidine
    Sponsors:   Weill Medical College of Cornell University;   Celgene Corporation
    Not yet recruiting - verified October 2009

  • Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

    Condition:   Pre-diabetes
    Intervention:   Behavioral: Project HEED (Help Educate to Eliminate Diabetes), a community-based, peer-led weight loss program for overweight adults with pre-diabetes.
    Sponsors:   Mount Sinai School of Medicine;   Union Memorial Hospital;   NORTH GENERAL HOSPITAL;   Albert Einstein College of Medicine of Yeshiva University
    Recruiting - verified October 2009

  • Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection

    Condition:   Melanoma
    Intervention:   Behavioral: screening questionnaire
    Sponsors:   Memorial Sloan-Kettering Cancer Center;   University of British Columbia;   San Diego State University;   Stony Brook University
    Recruiting - verified October 2009

  • Acupuncture for the Treatment of Chronic Lymphedema

    Conditions:   Breast Cancer;   Lymphedema
    Intervention:   Procedure: Acupuncture
    Sponsor:   Memorial Sloan-Kettering Cancer Center
    Recruiting - verified October 2009

  • A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials